These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7669262)

  • 1. ACE inhibitors. Drug interactions of clinical significance.
    Mignat C; Unger T
    Drug Saf; 1995 May; 12(5):334-47. PubMed ID: 7669262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic drug interactions with ACE inhibitors.
    Shionoiri H
    Clin Pharmacokinet; 1993 Jul; 25(1):20-58. PubMed ID: 8354016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE inhibitors and the kidney. A risk-benefit assessment.
    Navis G; Faber HJ; de Zeeuw D; de Jong PE
    Drug Saf; 1996 Sep; 15(3):200-11. PubMed ID: 8879974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of drug interactions with lithium.
    Finley PR; Warner MD; Peabody CA
    Clin Pharmacokinet; 1995 Sep; 29(3):172-91. PubMed ID: 8521679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The value of angiotensin-converting enzyme inhibitors in the treatment of hypertension].
    Klaus D
    Z Kardiol; 1988; 77 Suppl 3():73-88. PubMed ID: 3062960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE inhibitors in elderly patients with hypertension. Special considerations.
    Ravid M; Ravid D
    Drugs Aging; 1996 Jan; 8(1):29-37. PubMed ID: 8785466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal and electrolyte complications of congestive heart failure and effects of therapy with angiotensin-converting enzyme inhibitors.
    Oster JR; Materson BJ
    Arch Intern Med; 1992 Apr; 152(4):704-10. PubMed ID: 1558426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update.
    Parish RC; Miller LJ
    Drug Saf; 1992; 7(1):14-31. PubMed ID: 1536695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined use of an ACE-inhibitor and spironolactone in patients with heart insufficiency.
    Schröder J; Goltz L; Knoth H
    Med Monatsschr Pharm; 2017 Jan; 40(1):24-6. PubMed ID: 29952529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors associated with a high velocity of the development of hyperkalaemia in hospitalised patients.
    Indermitte J; Burkolter S; Drewe J; Krähenbühl S; Hersberger KE
    Drug Saf; 2007; 30(1):71-80. PubMed ID: 17194172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme inhibitors and moderate hypertension.
    McAreavey D; Robertson JI
    Drugs; 1990 Sep; 40(3):326-45. PubMed ID: 2226219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of concomitant potassium-sparing diuretics in angiotensin-converting enzyme inhibitor therapy in severe congestive heart failure. Xamoterol in Severe Heart Failure Study Group.
    Bergler-Klein J; Sochor H; Pouleur H; Pacher R; Porenta G; Glogar D
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):194-8. PubMed ID: 7526050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of ACE inhibitor therapies in patients with chronic kidney disease.
    Sidorenkov G; Navis G
    Expert Opin Drug Saf; 2014 Oct; 13(10):1383-95. PubMed ID: 25148900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE inhibitors. Differential use in elderly patients with hypertension.
    Israili ZH; Hall WD
    Drugs Aging; 1995 Nov; 7(5):355-71. PubMed ID: 8573991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diuretics potentiate angiotensin converting enzyme inhibitor-induced acute renal failure.
    Mandal AK; Markert RJ; Saklayen MG; Mankus RA; Yokokawa K
    Clin Nephrol; 1994 Sep; 42(3):170-4. PubMed ID: 7994935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE inhibitors and diuretics causing hypokalaemia.
    D'Costa DF; Basu SK; Gunasekera NP
    Br J Clin Pract; 1990 Jan; 44(1):26-7. PubMed ID: 2317435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal disease.
    Sica DA; Gehr TW; Fernandez A
    Drug Saf; 2000 May; 22(5):350-60. PubMed ID: 10830252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.